X
All Data
Upgrade this company profile, update & customize all content// Ask PharmaCompass, click HERE
Lead Product(s): Vancomycin Hydrochloride
Therapeutic Area: Infections and Infectious Diseases Product Name: Vanco Ready
Highest Development Status: Approved Product Type: Small molecule
Partner/Sponsor/Collaborator: Not Applicable
Deal Size: Not Applicable Upfront Cash: Not Applicable
Deal Type: Not Applicable September 02, 2020
Details:
Xellia Pharmaceuticals has received approval for 3 additional dosages of VANCO READY™, expanding its range of room-temperature-stable, ready-to-use (RTU) Vancomycin injection premix bags.
Upgrade this company profile, update & customize all content// Ask PharmaCompass, click HERE
Lead Product(s): MVA-BN
Therapeutic Area: Infections and Infectious Diseases Product Name: MVA-BN
Highest Development Status: Approved Product Type: Vaccine
Partner/Sponsor/Collaborator: Not Applicable
Deal Size: Not Applicable Upfront Cash: Not Applicable
Deal Type: Not Applicable August 24, 2020
Details:
The three lots of MVA-BN induced similar antibody responses, meeting the study's primary endpoint, while the favourable safety profile was also confirmed without severe adverse reactions.
Active Pharmaceutical Ingredients
Finished Drug Formulations
Prices
Excipients
Services
Marketplace
